Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan

Transfusion

Volumn 55, Issue 7, 2015, Pages 1803-1811

  Niazi, Saifullah Khan ^a   Bhatti, Farhat Abbas ^a   Salamat, Nuzhat ^a   Ghani, Eijaz ^b   Tayyab, Muhammad ^a  

^a National Institute of Heart Diseases National University of Medical Sciences   (Pakistan)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA; HEPATITIS B ANTIGEN; HEPATITIS C ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; BLOOD EXAMINATION; BLOOD SAFETY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; MALE; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID AMPLIFICATION TEST; SERODIAGNOSIS; VIRUS LOAD; ADOLESCENT; BLOOD; CLINICAL TRIAL; DONOR SELECTION; MIDDLE AGED; PAKISTAN; PROCEDURES;

ADOLESCENT; ADULT; BLOOD DONORS; BLOOD SAFETY; DNA, VIRAL; DONOR SELECTION; FEMALE; HEPATITIS B ANTIGENS; HEPATITIS C ANTIGENS; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PAKISTAN; RNA, VIRAL;

EID: 84937023780     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13017     Document Type: Article

References (28)

1. Stramer SL, Glynn SA, Kleinman SH, et al., Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004; 351: 760-8.
2. Roth WK, Busch MP, Schuller A, et al., International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang 2012; 102: 82-90.
3. Hourfar MK, Jork C, Schottstedt V, et al., Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion 2008; 48: 1558-66.
4. Barbara JA,. NAT: perspectives for cellular components. Biologicals 1999; 27: 333-6.
5. Schottstedt V, Tuma W, Bünger G, et al., PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service. Biologicals 1998; 26: 101-4.
6. Roth WK, Weber M, Seifried E,. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet 1999; 353: 359-63.
7. Kazi BM., Standards and guidelines for blood transfusion services. Islamabad: Pakistan National Institute of Health, Federal Health Ministry, Government of Pakistan; 1999.
8. Sultan F, Mehmood T, Mahmood MT,. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience. Int J Infect Dis 2007; 11: 407-12.
9. Bhatti FA, Ullah Z, Salamat N, et al., Anti-hepatitis B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 2007; 47: 74-9.
10. Allain JP, Candotti D,. Diagnostic algorithm for HBV safe transfusion. Blood Transfus 2009; 7: 174-82.
11. Busch MP, Glynn SA, Stramer SL, et al., A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45: 254-64.
12. Humar A, Morris M, Blumberg E, et al., Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report. Am J Transplant 2010; 10: 889-99.
13. Moiz B, Moatter T, Shaikh U, et al., Estimating window period blood donations for human immunodeficiency virus type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan. Transfusion 2014; 54: 1652-9.
14. Makroo RN, Choudhury N, Jagannathan L, et al., Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 & hepatitis B & C viruses in Indian blood donors. Indian J Med Res 2008; 127: 140-7.
15. Dong J, Wu Y, Zhu H, et al., A pilot study on screening blood donors with individual-donation nucleic acid testing in china. Blood Transfus 2014; 12: 172-9.
16. Li L, Chen PJ, Chen MH, et al., A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 2008; 48: 1198-206.
17. Phikulsod S, Oota S, Tirawatnapong T, et al., One-year experience of nucleic acid technology testing for human immunodeficiency virus type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009; 49: 1126-35.
18. Zou S, Dorsey KA, Notari EP, et al., Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010; 50: 1495-504.
19. Louisirirotchanakul S, Oota S, Khuponsarb K, et al., Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011; 51: 1532-40.
20. Yang Z, Xu L, Liu L, et al., Routine screening of blood donations at Qingdao Central Blood Bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus types 1 and 2. Transfusion 2013; 53: 2538-44.
21. Satake M, Taira R, Yugi H, et al., Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007; 47: 1197-205.
22. Taira R, Satake M, Momose S, et al., Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan. Transfusion 2013; 53: 1393-404.
23. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, et al., Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008; 48: 1022-5.
24. Stolz M, Tinguely C, Fontana S, et al., Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors. Transfusion 2014; 54: 2961-7.
25. Ilyas M, Asad S, Ali L, et al., A situational analysis of HIV and AIDS in Pakistan. Virol J 2011; 8: 191
26. Irfan SM, Uddin J, Zaheer HA, et al., Trends in transfusion transmitted infections among replacement blood donors in Karachi, Pakistan. Turk J Haematol 2013; 30: 163-7.
27. Comanor L, Holl P,. Hepatitis B virus blood screening: unfinished agendas. Vox Sang 2006; 91: 1-12.
28. Guidance for industry: nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry. Silver Spring (MD): U.S. Food and Drug Administration, Center for Biologics Evaluation and Research; 2010.